Ca2+ Influx through Store-operated Calcium Channels Replenishes the Functional Phosphatidylinositol 4,5-Bisphosphate Pool Used by Cysteinyl Leukotriene Type I Receptors

Store-Operated Ca2+ Channels: Mechanism, Function, Pharmacology, and Therapeutic Targets

Calcium (Ca²⁺) release-activated Ca²⁺ (CRAC) channels are a major route for Ca²⁺ entry in eukaryotic cells. These channels are store operated, opening when the endoplasmic reticulum (ER) is depleted of Ca²⁺, and are composed of the ER Ca²⁺ sensor protein STIM and the pore-forming plasma membrane subunit Orai. Recent years have heralded major strides in our understanding of the structure, gating, and function of the channels. Loss-of-function and gain-of-function mutants combined with RNAi knockdown strategies have revealed important roles for the channel in numerous human diseases, making the channel a clinically relevant target. Drugs targeting the channels generally lack specificity or exhibit poor efficacy in animal models. However, the landscape is changing, and CRAC channel blockers are now entering clinical trials. Here, we describe the key molecular and biological features of CRAC channels, consider various diseases associated with aberrant channel activity, and discuss targeting of the channels from a therapeutic perspective.

Signaling through Ca2+ Microdomains from Store-Operated CRAC Channels

Calcium (Ca²⁺) ion microdomains are subcellular regions of high Ca²⁺ concentration that develop rapidly near open Ca²⁺ channels in the plasma membrane or internal stores and generate local regions of high Ca²⁺ concentration. These microdomains are remarkably versatile in that they activate a range of responses that differ enormously in both their temporal and spatial profile. In this review, we describe how Ca²⁺ microdomains generated by store-operated calcium channels, a widespread and conserved Ca²⁺ entry pathway, stimulate different signaling pathways, and how the spatial extent of a Ca²⁺ microdomain can be influenced by Ca²⁺ ATPase pumps.

Analysis of Mrgprb2 Receptor-Evoked Ca 2+ Signaling in Bone Marrow Derived (BMMC) and Peritoneal (PMC) Mast Cells of TRPC-Deficient Mice

Mast cells are a heterogeneous group of immune cells. The simplest and commonly accepted classification divides them in two groups according to their protease content. We have compared the action of diverse secretagogues on bone marrow derived (BMMC) and peritoneal (PMC) mast cells which represent classical models of mucosal and connective tissue type mast cells in mice. Whereas, antigen stimulation of the FcεRI receptors was similarly effective in triggering elevations of free intracellular Ca²⁺ concentration ([Ca²⁺]_i) in both BMMC and PMC, robust [Ca²⁺]_i rise following Endothelin-1 stimulation was observed only in a fraction of BMMC. Leukotriene C4 activating cysteinyl leukotriene type I receptors failed to evoke [Ca²⁺]_i rise in either mast cell model. Stimulation of the recently identified target of many small-molecule drugs associated with systemic pseudo-allergic reactions, Mrgprb2, with compound 48/80, a mast cell activator with unknown receptor studied for many years, triggered Ca²⁺ oscillations in BMMC and robust [Ca²⁺]_i rise in PMCs similarly to that evoked by FcεRI stimulation. [Ca²⁺]_i rise in PMC could also be evoked by other Mrgprb2 agonists such as Tubocurarine, LL-37, and Substance P. The extent of [Ca²⁺]_i rise correlated with mast cell degranulation. Expression analysis of TRPC channels as potential candidates mediating agonist evoked Ca²⁺ entry revealed the presence of transcripts of all members of the TRPC subfamily of TRP channels in PMCs. The amplitude and AUC of compound 48/80-evoked [Ca²⁺]_i rise was reduced by ~20% in PMC from Trpc1/4/6^−/− mice compared to Trpc1/4^−/− littermatched control mice, whereas FcεRI-evoked [Ca²⁺]_i rise was unaltered. Whole-cell patch clamp recordings showed that the reduction in compound 48/80-evoked [Ca²⁺]_i rise in Trpc1/4/6^−/− PMC was accompanied by a reduced amplitude of Compound 48/80-induced cation currents which exhibited typical features of TRPC currents. Together, this study demonstrates that PMC are an appropriate mast cell model to study mechanisms of Mrgprb2 receptor-mediated mast cell activation, and it reveals that TRPC channels contribute at least partially to Mrgprb2-mediated mast cellactivation but not following FcεRI stimulation. However, the channels conducting most of the Ca²⁺ entry in mast cells triggered by Mrgprb2 receptor stimulation remains to be identified.

Striated muscle-specific serine/threonine-protein kinase beta segregates with high versus low responsiveness to endurance exercise training

Bidirectional selection for either high or low responsiveness to endurance running has created divergent rat phenotypes of high-response trainers (HRT) and low-response trainers (LRT). We conducted proteome profiling of HRT and LRT gastrocnemius of 10 female rats (body weight 279 ± 35 g; n = 5 LRT and n = 5 HRT) from generation 8 of selection. Differential analysis of soluble proteins from gastrocnemius was conducted by label-free quantitation. Genetic association studies were conducted in 384 Russian international-level athletes (age 23.8 ± 3.4 yr; 202 men and 182 women) stratified to endurance or power disciplines. Proteomic analysis encompassed 1,024 proteins, 76 of which exhibited statistically significant (P < 0.05, false discovery rate <1%) differences between HRT and LRT muscle. There was significant enrichment of enzymes involved in glycolysis/gluconeogenesis in LRT muscle but no enrichment of gene ontology phrases in HRT muscle. Striated muscle-specific serine/threonine-protein kinase-beta (SPEG-β) exhibited the greatest difference in abundance and was 2.64-fold greater (P = 0.0014) in HRT muscle. Coimmunoprecipitation identified 24 potential binding partners of SPEG-β in HRT muscle. The frequency of the G variant of the rs7564856 polymorphism that increases SPEG gene expression was significantly greater (32.9 vs. 23.8%; OR = 1.6, P = 0.009) in international-level endurance athletes (n = 258) compared with power athletes (n = 126) and was significantly associated (β = 8.345, P = 0.0048) with a greater proportion of slow-twitch fibers in vastus lateralis of female endurance athletes. Coimmunoprecipitation of SPEG-β in HRT muscle discovered putative interacting proteins that link with previously reported differences in transforming growth factor-β signaling in exercised muscle.

Na-K-2Cl Cotransporter and Store-Operated Ca2+ Entry in Pacemaking by Interstitial Cells of Cajal

Pacemaker depolarization in interstitial cells of Cajal (ICCs) is believed to be induced by Ca²⁺ transients and activation of anoctamin-1 (Ano1) channels in the plasma membrane. However, block of store-operated calcium entry (SOCE) or the Na-K-2Cl cotransporter (NKCC1) terminates pacemaker activity in ICC, indicating these transporters are involved in the initiation or maintenance of pacemaker activity. We hypothesized that SOCE contributes to pacemaker depolarization by maintaining [Ca²⁺] in the endoplasmic reticulum, which is the underlying source of Ca²⁺ transients for activation of Ano1. NKCC1 maintains the Cl^- gradient supporting the driving force for inward current mediated by Ano1. Currently mechanisms sustaining release of Ca²⁺ and activation of Ano1 channels during the plateau phase of slow waves are unknown, but the reverse mode of the Na⁺/Ca²⁺ exchange may contribute. We generated a mathematical model of pacemaker activity based on current empirical observations from ICC of mouse small intestine that incorporates functions of SOCE and NKCC1. This model reproduces experimental findings, suggesting roles for SOCE and Ano1 channels: blocking of either NKCC1 or SOCE in our model terminates pacemaker activity. Direct contribution of NKCC1 to pacemaker activity in a beat-to-beat manner is not predicted by our model. Instead, NKCC1 plays a maintenance role supporting the driving force for Cl^- efflux. Incorporation of SOCE allows the model to drive pacemaker activity without a diastolic depolarization, as observed in cardiac pacemaking. Further biological experiments are necessary to validate and further refine the roles of NKCC1, Na⁺/Ca²⁺ exchange, and Ano1 in the pacemaker mechanism of ICC.

The whole-cell Ca2+ release-activated Ca2+ current, ICRAC , is regulated by the mitochondrial Ca2+ uniporter channel and is independent of extracellular and cytosolic Na. J Physiol 2019;598:1753-1773. [PMID: 30582626 PMCID: PMC7318671 DOI: 10.1113/jp276551]

Key points

Ca²⁺ entry through Ca²⁺ release‐activated Ca²⁺ channels activates numerous cellular responses. Under physiological conditions of weak intracellular Ca²⁺ buffering, mitochondrial Ca²⁺ uptake regulates CRAC channel activity.

Knockdown of the mitochondrial Ca²⁺ uniporter channel prevented the development of I_CRAC in weak buffer but not when strong buffer was used instead.

Removal of either extracellular or intra‐pipette Na⁺ had no effect on the selectivity, kinetics, amplitude, rectification or reversal potential of whole‐cell CRAC current.

Knockdown of the mitochondrial Na⁺–Ca²⁺ exchanger did not prevent the development of I_CRAC in strong or weak Ca²⁺ buffer.

Whole cell CRAC current is Ca²⁺‐selective.

Mitochondrial Ca²⁺ channels, and not Na⁺‐dependent transport, regulate CRAC channels under physiological conditions.

Abstract

Ca²⁺ entry through store‐operated Ca²⁺ release‐activated Ca²⁺ (CRAC) channels plays a central role in activation of a range of cellular responses over broad spatial and temporal bandwidths. Mitochondria, through their ability to take up cytosolic Ca²⁺, are important regulators of CRAC channel activity under physiological conditions of weak intracellular Ca²⁺ buffering. The mitochondrial Ca²⁺ transporter(s) that regulates CRAC channels is unclear and could involve the 40 kDa mitochondrial Ca²⁺ uniporter (MCU) channel or the Na⁺–Ca²⁺–Li⁺ exchanger (NCLX). Here, we have investigated the involvement of these mitochondrial Ca²⁺ transporters in supporting the CRAC current (I_CRAC) under a range of conditions in RBL mast cells. Knockdown of the MCU channel impaired the activation of I_CRAC under physiological conditions of weak intracellular Ca²⁺ buffering. In strong Ca²⁺ buffer, knockdown of the MCU channel did not inhibit I_CRAC development demonstrating that mitochondria regulate CRAC channels under physiological conditions by buffering of cytosolic Ca²⁺ via the MCU channel. Surprisingly, manipulations that altered extracellular Na⁺, cytosolic Na⁺ or both failed to inhibit the development of I_CRAC in either strong or weak intracellular Ca²⁺ buffer. Knockdown of NCLX also did not affect I_CRAC. Prolonged removal of external Na⁺ also had no significant effect on store‐operated Ca²⁺ entry, on cytosolic Ca²⁺ oscillations generated by receptor stimulation or on CRAC channel‐driven gene expression. In the RBL mast cell, Ca²⁺ flux through the MCU but not NCLX is indispensable for activation of I_CRAC.

Ca²⁺ entry through Ca²⁺ release‐activated Ca²⁺ channels activates numerous cellular responses. Under physiological conditions of weak intracellular Ca²⁺ buffering, mitochondrial Ca²⁺ uptake regulates CRAC channel activity.

Knockdown of the mitochondrial Ca²⁺ uniporter channel prevented the development of I_CRAC in weak buffer but not when strong buffer was used instead.

Removal of either extracellular or intra‐pipette Na⁺ had no effect on the selectivity, kinetics, amplitude, rectification or reversal potential of whole‐cell CRAC current.

Knockdown of the mitochondrial Na⁺–Ca²⁺ exchanger did not prevent the development of I_CRAC in strong or weak Ca²⁺ buffer.

Whole cell CRAC current is Ca²⁺‐selective.

Mitochondrial Ca²⁺ channels, and not Na⁺‐dependent transport, regulate CRAC channels under physiological conditions.

Conversion of phosphatidylinositol (PI) to PI4-phosphate (PI4P) and then to PI(4,5)P2 is essential for the cytosolic Ca2+ concentration under heat stress in Ganoderma lucidum

How cells drive the phospholipid signal response to heat stress (HS) to maintain cellular homeostasis is a fundamental issue in biology, but the regulatory mechanism of this fundamental process is unclear. Previous quantitative analyses of lipids showed that phosphatidylinositol (PI) accumulates after HS in Ganoderma lucidum, implying the inositol phospholipid signal may be associated with HS signal transduction. Here, we found that the PI-4-kinase and PI-4-phosphate-5-kinase activities are activated and that their lipid products PI-4-phosphate and PI-4,5-bisphosphate are increased under HS. Further experimental results showed that the cytosolic Ca²⁺ ([Ca²⁺ ]_c ) and ganoderic acid (GA) contents induced by HS were decreased when cells were pretreated with Li⁺ , an inhibitor of inositol monophosphatase, and this decrease could be rescued by PI and PI-4-phosphate. Furthermore, inhibition of PI-4-kinases resulted in a decrease in the Ca²⁺ and GA contents under HS that could be rescued by PI-4-phosphate but not PI. However, the decrease in the Ca²⁺ and GA contents by silencing of PI-4-phosphate-5-kinase could not be rescued by PI-4-phosphate. Taken together, our study reveals the essential role of the step converting PI to PI-4-phosphate and then to PI-4,5-bisphosphate in [Ca²⁺ ]_c signalling and GA biosynthesis under HS.

Cyclic AMP Recruits a Discrete Intracellular Ca2+ Store by Unmasking Hypersensitive IP3 Receptors

Inositol 1,4,5-trisphosphate (IP₃) stimulates Ca²⁺ release from the endoplasmic reticulum (ER), and the response is potentiated by 3′,5′-cyclic AMP (cAMP). We investigated this interaction in HEK293 cells using carbachol and parathyroid hormone (PTH) to stimulate formation of IP₃ and cAMP, respectively. PTH alone had no effect on the cytosolic Ca²⁺ concentration, but it potentiated the Ca²⁺ signals evoked by carbachol. Surprisingly, however, the intracellular Ca²⁺ stores that respond to carbachol alone could be both emptied and refilled without affecting the subsequent response to PTH. We provide evidence that PTH unmasks high-affinity IP₃ receptors within a discrete Ca²⁺ store. We conclude that Ca²⁺ stores within the ER that dynamically exchange Ca²⁺ with the cytosol maintain a functional independence that allows one store to be released by carbachol and another to be released by carbachol with PTH. Compartmentalization of ER Ca²⁺ stores adds versatility to IP₃-evoked Ca²⁺ signals.

•

Cyclic AMP directly potentiates IP₃-evoked Ca²⁺ release

•

The Ca²⁺ stores released by IP₃ alone or IP₃ with cAMP are functionally independent

•

Cyclic AMP unmasks high-affinity IP₃ receptors in a discrete ER Ca²⁺ store

•

Independent regulation of discrete Ca²⁺ stores increases signaling versatility

A Quininib Analogue and Cysteinyl Leukotriene Receptor Antagonist Inhibits Vascular Endothelial Growth Factor (VEGF)-independent Angiogenesis and Exerts an Additive Antiangiogenic Response with Bevacizumab

Excess blood vessel growth contributes to the pathology of metastatic cancers and age-related retinopathies. Despite development of improved treatments, these conditions are associated with high economic costs and drug resistance. Bevacizumab (Avastin®), a monoclonal antibody against vascular endothelial growth factor (VEGF), is used clinically to treat certain types of metastatic cancers. Unfortunately, many patients do not respond or inevitably become resistant to bevacizumab, highlighting the need for more effective antiangiogenic drugs with novel mechanisms of action. Previous studies discovered quininib, an antiangiogenic small molecule antagonist of cysteinyl leukotriene receptors 1 and 2 (CysLT₁ and CysLT₂). Here, we screened a series of quininib analogues and identified a more potent antiangiogenic novel chemical entity (IUPAC name (E)-2-(2-quinolin-2-yl-vinyl)-benzene-1,4-diol HCl) hereafter designated Q8. Q8 inhibits developmental angiogenesis in Tg(fli1:EGFP) zebrafish and inhibits human microvascular endothelial cell (HMEC-1) proliferation, tubule formation, and migration. Q8 elicits antiangiogenic effects in a VEGF-independent in vitro model of angiogenesis and exerts an additive antiangiogenic response with the anti-VEGF biologic bevacizumab. Cell-based receptor binding assays confirm that Q8 is a CysLT₁ antagonist and is sufficient to reduce cellular levels of NF-κB and calpain-2 and secreted levels of the proangiogenic proteins intercellular adhesion molecule-1, vascular cell adhesion protein-1, and VEGF. Distinct reductions of VEGF by bevacizumab explain the additive antiangiogenic effects observed in combination with Q8. In summary, Q8 is a more effective antiangiogenic drug compared with quininib. The VEGF-independent activity coupled with the additive antiangiogenic response observed in combination with bevacizumab demonstrates that Q8 offers an alternative therapeutic strategy to combat resistance associated with conventional anti-VEGF therapies.

Fine tuning of cytosolic Ca (2+) oscillations

Ca ²⁺ oscillations, a widespread mode of cell signaling, were reported in non-excitable cells for the first time more than 25 years ago. Their fundamental mechanism, based on the periodic Ca ²⁺ exchange between the endoplasmic reticulum and the cytoplasm, has been well characterized. However, how the kinetics of cytosolic Ca ²⁺ changes are related to the extent of a physiological response remains poorly understood. Here, we review data suggesting that the downstream targets of Ca ²⁺ are controlled not only by the frequency of Ca ²⁺ oscillations but also by the detailed characteristics of the oscillations, such as their duration, shape, or baseline level. Involvement of non-endoplasmic reticulum Ca ²⁺ stores, mainly mitochondria and the extracellular medium, participates in this fine tuning of Ca ²⁺ oscillations. The main characteristics of the Ca ²⁺ exchange fluxes with these compartments are also reviewed.